Bioxytran delays quarterly report after auditor proposes last-minute revisions
BIXT•
BIXT•Bioxytran delayed its Form 10-Q for the quarter ended September 30, 2026, after its auditor proposed significant last-minute disclosure revisions. The filing’s narrative anticipates submission within 15 days of the deadline, while its checked certification commits to five calendar days; Bioxytran does not anticipate a significant change in operating results from a year earlier.
Bioxytran said in a November 16 filing that limited accounting staff needed more time to incorporate significant last-minute disclosure revisions proposed by its independent auditor. The filing anticipates submission within 15 days of the deadline in its narrative, but its checked certification commits to five calendar days. The company does not anticipate a significant change in operating results from the year-earlier period.